Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Varian Software Successfully Connected with Siemens Linear Accelerators

13.06.2013
- Clinicians are now using Varian software to manage patient treatments on a Siemens Oncor medical linear accelerator

- FDA clearance for connectivity between Varian's ARIA oncology information system and Siemens' Linacs Oncor and Primus

Varian Medical Systems and Siemens Healthcare today announced that clinicians at The Ohio State University (Ohio State), USA, are now using Varian software to plan and manage radiotherapy treatments delivered on a Siemens medical linear accelerator.



The companies have developed and deployed an interface that connects Varian's ARIA oncology information system with Siemens' Oncor and Primus accelerators and imaging systems. This step – as part of the company's "Agenda 2013" sector initiative – demonstrates once again Siemens Healthcare's role as a strong partner for imaging systems in radiation oncology.

Clinicians at The Ohio State University, USA, are now using Varian software to plan and manage radiotherapy treatments delivered on a Siemens medical linear accelerator. Varian Medical Systems and Siemens Healthcare have developed and deployed an interface that connects Varian's ARIA oncology information system with Siemens' Oncor and Primus accelerators and imaging systems.

"Since we launched the global strategic partnership with Siemens last year, we have been steadily working to develop software interfaces that enable clinics with Siemens linear accelerators to manage patient care using Varian software," says Kolleen Kennedy, president of Varian's Oncology Systems business. "With this new interface, we can connect to about 80 percent of the Siemens equipment in the field. Now the majority of Siemens-equipped sites can choose to adopt ARIA for managing all aspects of care, from initial diagnosis through post-treatment follow-up."

In March of this year, Siemens received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for connectivity between Varian's ARIA software and Siemens' Oncor and Primus linear accelerators.

"Developing these interfaces was one of our main goals when we launched our partnership last year," says Walter Märzendorfer, CEO of Siemens Computed Tomography and Radiation Oncology. "We're pleased to have now released this interface and completed the first deployment at such a luminary U.S. treatment center. We would like to thank the team at The Ohio State University for valuable clinical input during the interface development process, and for helping our teams identify ways of enhancing the workflow when Varian software is used to manage treatment on a Siemens linear accelerator."

The deployment at Ohio State marks an important milestone in the two companies' cooperation. "This demonstrates our commitment to the community of Siemens technology users," Kennedy says. "It allows us to offer them a seamlessly integrated option for improving workflow and streamlining operations."

Varian has also launched a special service and support program to support oncology treatment centers converting to ARIA from other third-party oncology information systems, including the Lantis system from Siemens. The program is designed to provide data conversion, workflow consulting and application training, as well as software connectivity licenses.

The Siemens Healthcare Sector is one of the world's largest suppliers to the healthcare industry and a trendsetter in medical imaging, laboratory diagnostics, medical information technology and hearing aids. Siemens offers its customers products and solutions for the entire range of patient care from a single source – from prevention and early detection to diagnosis, and on to treatment and aftercare. By optimizing clinical workflows for the most common diseases, Siemens also makes healthcare faster, better and more cost-effective. Siemens Healthcare employs some 51,000 employees worldwide and operates around the world. In fiscal year 2012 (to September 30), the Sector posted revenue of 13.6 billion euros and profit of 1.8 billion euros. For further information please visit: http://www.siemens.com/healthcare

Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes, digital detectors, and image processing workstations for X-ray imaging in medical, scientific, and industrial applications and also supplies high-energy X-ray devices for cargo screening and non-destructive testing applications. Varian Medical Systems employs approximately 6,200 people who are located at manufacturing sites in North America, Europe, and China and approximately 70 sales and support offices around the world. For more information, visit http://www.varian.com.

Launched in November 2011, Agenda 2013 is an initiative of the Siemens Healthcare Sector to further strengthen its innovative power and competitiveness. Specific measures, which will be implemented by the end of 2013, have been defined in four fields of action: innovation, competitiveness, regional footprint, and people development.

The products/features (here mentioned) are not commercially available in all countries. Due to regulatory reasons their future availability cannot be guaranteed. Further details are available from the local Siemens organizations.

Reference Number: HIM201306019e

Contact
Mr. Ulrich Künzel
Healthcare Sector
Siemens AG
Henkestr. 127
91052 Erlangen
Germany
Tel: +49 (9131) 84-3473
Ulrich.Kuenzel@siemens.com
Ms. Meryl Ginsberg
Siemens AG
Tel: +1 (650) 424-6444
Meryl.Ginsberg@varian.com

Ulrich Künzel | Siemens Healthcare
Further information:
http://www.siemens.com/healthcare
http://www.varian.com

More articles from Medical Engineering:

nachricht Novel PET imaging agent could help guide therapy for brain diseases
03.04.2018 | Society of Nuclear Medicine and Molecular Imaging

nachricht New Computer Architecture: Time Lapse for Dementia Research
29.03.2018 | Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. (DZNE)

All articles from Medical Engineering >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Writing and deleting magnets with lasers

Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.

Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...

Im Focus: Gamma-ray flashes from plasma filaments

Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.

The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...

Im Focus: Basel researchers succeed in cultivating cartilage from stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem...

Im Focus: Like a wedge in a hinge

Researchers lay groundwork to tailor drugs for new targets in cancer therapy

In the fight against cancer, scientists are developing new drugs to hit tumor cells at so far unused weak points. Such a “sore spot” is the protein complex...

Im Focus: The Future of Ultrafast Solid-State Physics

In an article that appears in the journal “Review of Modern Physics”, researchers at the Laboratory for Attosecond Physics (LAP) assess the current state of the field of ultrafast physics and consider its implications for future technologies.

Physicists can now control light in both time and space with hitherto unimagined precision. This is particularly true for the ability to generate ultrashort...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

IWOLIA: A conference bringing together German Industrie 4.0 and French Industrie du Futur

09.04.2018 | Event News

 
Latest News

Diamond-like carbon is formed differently to what was believed -- machine learning enables development of new model

19.04.2018 | Materials Sciences

Electromagnetic wizardry: Wireless power transfer enhanced by backward signal

19.04.2018 | Physics and Astronomy

Ultrafast electron oscillation and dephasing monitored by attosecond light source

19.04.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>